2006年6月，FDA停止了一种含有卡比·沙明的药物的生产，这种药物的外部标签错误地标识，可以使用于婴幼儿和儿童。
In June 2006, the FDA took action to stop the manufacture of medications containing carbinoxamine (an antihistamine) which were inappropriately labeled for use in infants and young children.
2006年6月，FDA停止了一种含有卡比·沙明的药物的生产，这种药物的外部标签错误地标识，可以使用于婴幼儿和儿童。
In June 2006, the FDA took action to stop the manufacture of medications containing carbinoxamine (an antihistamine) which were inappropriately labeled for use in infants and young children.
应用推荐